UNSPSC 51292703: Metralindole

This classification denotes an antidepressant agent with the molecular formula C15H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2QW3FL6OPA, chemically known as 2,4,5,6-tetrahydro-9-methoxy-4-methyl-1h-3,4,6a-triazafluoranthene but generally known as metralindole, which bears US NIH Compound Identifier 68713. European Medicines Agency schedules Metralindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08915MIG.

UNSPSC 51292703 Metralindole is a Commodity code that, based on recent state and local opportunities, does not correspond to the actual pharmaceutical procurement activity being conducted. The three recent solicitations posted under this code involve naloxone procurement for opioid overdose response, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals distributed through authorized wholesalers—none of which involve metralindole specifically. State and local health agencies and cooperative purchasing alliances are the primary issuing bodies, with Seminole County in Florida, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) representing recent activity. The solicitations span community health initiatives, state pharmacy benefit programs, and multi-jurisdictional cooperative arrangements designed to manage pharmaceutical costs and supply chain efficiency across state and local government facilities.

Recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023; the Texas HHS Commission's RFI regarding direct-to-manufacturer prescription capabilities, posted April 3, 2026; and MMCAP's RFP for generic and over-the-counter pharmaceuticals serving Minnesota and Oregon participating entities, with proposals due March 26, 2026. The code shows activity concentrated in Florida, Texas, and the upper Midwest, though the mismatch between the nominal commodity name and the actual work being procured suggests the code may be misapplied to pharmaceutical procurement more broadly rather than to metralindole in particular.